Vertex islet cell therapy gets type 1 diabetics off insulin
pharmaphorum
JUNE 23, 2024
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 were able to come off insulin within a year
Sun.Jun 23, 2024
115 
20 years of X20
Express Pharma
JUNE 23, 2024
The X20 system has been an essential component of countless industrial applications for the last 20 years, providing dependable performance and pushing productivity to unprecedented levels. The X20 has transformed industrial automation with its small size and potent features, enabling machines all around the world to function accurately and effectively.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA clears Argenx’ Vyvgart Hytrulo for rare disease CIDP
pharmaphorum
JUNE 23, 2024
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it hopes could find a use in more than a dozen diseases.
The PCAT Is Going Away, Will NAPLEX Pass Rates Fall?
Med Ed 101
JUNE 23, 2024
How do you get better at something? Practice. At least that’s what I tell my kids. The (Pharmacy College Admissions Test) PCAT has gone away in 2024 and I can’t help but think that this will be another nail in the coffin of future high NAPLEX pass rates. The PCAT was a good avenue for […] The post The PCAT Is Going Away, Will NAPLEX Pass Rates Fall?
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Episode 933: Can tenecteplase be used for acute ischemic stroke beyond 4.5 hours from time last know well?
Pharmacy Joe
JUNE 23, 2024
In this episode, I’ll discuss tenecteplase for stroke from 4.5 to 24 hours after the time last know well. Episode 933: Can tenecteplase be used for acute ischemic stroke beyond 4.5 hours from time last know well? Subscribe on iTunes , Android , or Stitcher While the use of thrombolytics for patients with acute ischemic stroke is usually done if the patient presents within 4.5 hours of the time last know well, data specifically with tenecteplase beyond the 4.5 hour window is sparse.
EMA approves Biocon’s new mAbs facility in India
Express Pharma
JUNE 23, 2024
Biocon Biologics a subsidiary of Biocon, has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new, multi-product monoclonal antibodies (mAbs) drug substance facility at Bengaluru. The facility was previously approved to manufacture biosimilar Trastuzumab in September 2022. The company also announced that EMA has renewed its Good Manufacturing Practice (GMP) Certificates of Compliance for its biosimilar manufacturing facility in Bengaluru a
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
A throughput benchmarking study of Supor™ Prime filters
PharmaTech
JUNE 23, 2024
See how Supor Prime filters performed against two comparable products in filtering fluids with antibody concentrations of 70 g/L to 220 g/L. And be sure to request a sample!
Which pharmaceutical companies have the most SPCs in Italy?
Drug Patent Watch
JUNE 23, 2024
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long time needed to obtain regulatory approval for drugs.
Educational Nutrition Programs Targeted at Communities Improve Diabetes Outcomes
Pharmacy Times
JUNE 23, 2024
Food is medicine is a framework of policy and behavioral interventions, improving population health through access to healthy foods to increase food and nutrition security.
New tentative approval for Alembic drug dabigatran etexilate mesylate
Drug Patent Watch
JUNE 23, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug patent litigation for DABIGATRAN ETEXILATE MESYLATE. Nine suppliers are listed for this compound.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Experts Discuss Serious Adverse Events for GLP-1 Medications
Pharmacy Times
JUNE 23, 2024
Potential concerns surrounding GLP-include pancreatitis, pancreatic cancer, colorectal cancer, suicide and other phycological effects, and thyroid cancer.
Drug Patent Expirations for the Week of June 23, 2024
Drug Patent Watch
JUNE 23, 2024
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
Implementing Community Health Workers into Pharmacy Reduces Health Equities, SDOH
Pharmacy Times
JUNE 23, 2024
Adding a community health worker can improve the overall health equity for your patients.
Opinion: The FDA needs to embrace phage therapy to help fight antimicrobial resistance
STAT
JUNE 23, 2024
My daughter, Mallory, died in 2017 at the age of 25 from a multiply resistant bacterial lung infection that followed a double-lung transplant necessitated by cystic fibrosis. In the weeks before her death, my wife, Diane Shader Smith, and I sought out and obtained an innovative yet underused treatment for antibiotic-resistant bacteria known as phage therapy.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Managing Diabetes and Cardiovascular Risk Through Collaborative Care
Pharmacy Times
JUNE 23, 2024
Jennifer Goldman discusses the importance of collaborative care between providers like endocrinologists, cardiologists, primary care physicians, and pharmacists to manage diabetes and prevent cardiovascular events.
DEA’s Expected Guidance: It Should Reduce Current “Pain” at the (Intrathecal Pain) Pump Dispensing Process and Improve Therapeutic Outcomes
FDA Law Blog: Biosimilars
JUNE 23, 2024
By John A. Gilbert & Karla L. Palmer — For more than 50 years, the Drug Enforcement Administration (DEA) has enforced the central mandate of the Controlled Substances Act (CSA) to maintain a closed chain of distribution for drugs with a potential for abuse and diversion. The CSA and regulations promulgated by DEA are intended to reduce the potential for diversion and abuse and ensure that controlled substances are dispensed and delivered to patients for a legitimate medical purpose.
Physician Calls for National Dialogue on Inequitable Access to Lifesaving GLP-1 Medications
Pharmacy Times
JUNE 23, 2024
W. Timothy Garvey expressed concern over limited access to effective obesity medications like Ozempic due to shortages and high costs, urging stakeholders to work together on developing solutions.
Expert: Supporting Health Equity and Access to Care Through Community Pharmacies
Pharmacy Times
JUNE 23, 2024
Niki Shah Vice President of Impact Innovation and Activation at McKesson, discusses efforts to advance health equity and access through community pharmacy initiatives.
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Expert: Semaglutide's Benefits in Obesity-Related Heart Failure, the Role of Pharmacists in Diabetes Care
Pharmacy Times
JUNE 23, 2024
Semaglutide significantly improved heart failure symptoms and quality of life through weight loss and direct effects on heart tissue.
Let's personalize your content